Bio

Francois Maisonrouge is a Senior Managing Director in Evercore’s Advisory business with 35 years of relevant experience. At Evercore, among other transactions, Mr. Maisonrouge was involved in advising AstraZeneca on its acquisition of Alexion, Sanofi on its acquisition of Principia, Nestlé on its sale of Nestlé Skin Health to EQT and ADIA, Bristol-Myers Squibb on its acquisition of Celgene, Takeda on its acquisition of Shire, AstraZeneca on its defense across from Pfizer, and Sun Pharmaceutical Industries on its acquisition of Ranbaxy Laboratories from Daiichi-Sankyo. In addition, Mr. Maisonrouge has been involved in a large number of IPOs and follow-on equity offerings, principally for biotech companies. Prior to joining Evercore, Mr. Maisonrouge was a Managing Director and Chairman of Life Sciences at Credit Suisse where he worked extensively in the fields of pharmaceuticals, specialty pharmaceuticals, biotechnology and medical technology. Mr. Maisonrouge holds an M.S. in Engineering from Ecole Centrale de Lyon and an M.B.A. from Harvard Business School. He is a member of the Board of Advisors of the Harvard Business School Health Care Initiative, and the Chairman of the Pasteur Foundation. In 2014, Mr. Maisonrouge was awarded the rank of Chevalier de la Légion d’Honneur.